drugset / Trial / NCT00160498

Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients

NCT00160498

Completed 180 enrolled UCB Pharma
RandomizedParallel-groupDouble-blind

Summary

A double blind study to examine the safety and efficacy of different dosages of lercanidipine in normal weight and obese patients with hypertension

Timeline

Start
2004-05
Primary completion
2005-08
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lercanidipine Small molecule 10 mg Oral
Subject Lercanidipine Small molecule 20 mg Oral

Indications